The Journal of Pharmaceutical Investigation, a peer-reviewed publication covering research on drug development, formulation, and pharmaceutical technology, has been abstracted and indexed in Science Citation Index Expanded, commonly known as SciSearch, since 2021. The indexing milestone places the journal within the Web of Science Core Collection ecosystem, a bibliographic database maintained by Clarivate that many researchers, librarians, and institutions treat as a benchmark for scholarly visibility and quality control in the natural sciences.
Indexing in SciSearch means that articles published in the journal are systematically cataloged, with structured metadata including author names, affiliations, abstracts, and cited references. This infrastructure allows the journal’s output to be discovered through standardized searches, tracked for citation activity, and aggregated into bibliometric analyses. For authors, inclusion in the database ensures that their work is counted in institutional assessments and that citations to their papers are captured in the citation indexes that underpin modern research evaluation.
Alongside the indexing achievement, the journal recorded an Impact Factor of 5.5 in 2022, according to the source announcement. Within the Journal Citation Reports category of Pharmacology and Pharmacy, that figure corresponded to a Q1 quartile ranking, placing the journal 48th out of 278 titles in the category. Quartile rankings divide journals in a category into four groups by citation performance, and Q1 designates the top quarter, a status widely regarded as an indicator of strong relative influence within a field.
The Impact Factor itself is calculated from citations accrued in a given year to items published in the two preceding years, divided by the number of citable items published in that window. A score of 5.5 indicates that, on average, recent articles in the journal were cited more than five times within the measurement period. While bibliometricians caution that the metric reflects aggregate citation behavior rather than the quality of any individual paper, it remains one of the most consulted indicators when researchers choose where to submit manuscripts and when libraries decide which subscriptions to maintain.
For a journal focused on pharmaceutical investigation, the Q1 position in Pharmacology and Pharmacy carries particular weight. The category is crowded and competitive, spanning basic pharmacology, clinical pharmacy practice, drug delivery science, and regulatory science. Ranking 48th of 278 means the journal sits comfortably within the upper tier of a broad and active field, competing for attention with long-established titles that have decades of accumulated citation history.
The timing of the SciSearch indexing in 2021 is significant for the journal’s trajectory. Journals typically need a period of consistent publication and editorial rigor before they are evaluated for Web of Science coverage, and newly indexed titles generally receive their first Impact Factor only after a full citation window has elapsed. The 2022 Impact Factor therefore represents an early but meaningful validation of the journal’s growing footprint in the pharmaceutical sciences literature.
From the perspective of the research community, expanded indexing and strong citation metrics have practical consequences. Manuscript submissions tend to rise as visibility increases, which in turn allows editorial teams to be more selective. Authors in drug delivery, pharmacokinetics, and pharmaceutical formulation often weigh indexing status heavily because funding agencies and promotion committees in many countries explicitly require publications in Web of Science–indexed journals. The journal’s inclusion removes a barrier for authors in those systems and broadens its potential contributor base across Asia, Europe, and the Americas.
Librarians and information scientists also benefit from the development. Abstracting and indexing services create the connective tissue of scholarly communication: without them, discovering relevant articles across thousands of journals would be impractical. Coverage in SciSearch ensures that the journal’s content is integrated into discovery platforms used by universities and industry research groups, supporting systematic reviews, competitor intelligence in pharmaceutical R&D, and citation network analyses that map emerging research fronts in drug development.
The announcement, published through Springer’s journal updates for the Journal of Pharmaceutical Investigation, highlights how indexing and citation performance function as complementary signals. Indexing establishes that a journal meets baseline editorial and technical standards, while the Impact Factor and quartile ranking describe how its published work resonates with the research community. Together, they offer a concise summary of the journal’s standing: a title that has entered the mainstream of indexed pharmacology literature and, within two years, achieved a top-quartile citation profile in its category.
As the pharmaceutical sciences continue to expand, with growing attention to biologics, nanomedicine, and personalized drug delivery, the visibility provided by comprehensive indexing will shape which journals anchor the field’s scholarly record. For the Journal of Pharmaceutical Investigation, the 2021 SciSearch inclusion and the 2022 Impact Factor of 5.5, with its Q1 ranking of 48 out of 278 in Pharmacology and Pharmacy, mark a notable consolidation of its position among the publications that researchers in the discipline consult, cite, and trust.
Subject of Research: Abstracting and indexing of the Journal of Pharmaceutical Investigation in Science Citation Index Expanded and its 2022 Impact Factor of 5.5 with a Q1 ranking in Pharmacology and Pharmacy
Article Title: Abstracting and Indexing
Article References: Abstracting and Indexing. (n.d.). Original publication
Image Credits: AI Generated
DOI: Not provided
Keywords: Journal of Pharmaceutical Investigation, abstracting and indexing, Science Citation Index Expanded, SciSearch, Impact Factor, Q1 journal, Pharmacology and Pharmacy, Web of Science, pharmaceutical sciences, journal citation metrics, Springer, scholarly publishing
Cite Scienmag News
APA
MLA
Chicago
Louis Brooks. (September 22, 2026). Journal of Pharmaceutical Investigation Gains SciSearch Coverage and Q1 Impact Factor Standing. Scienmag. https://scienmag.com/journal-of-pharmaceutical-investigation-gains-scisearch-coverage-and-q1-impact-factor-standing/
Louis Brooks. “Journal of Pharmaceutical Investigation Gains SciSearch Coverage and Q1 Impact Factor Standing.” Scienmag, 22 September 2026, https://scienmag.com/journal-of-pharmaceutical-investigation-gains-scisearch-coverage-and-q1-impact-factor-standing/. Accessed 23 September 2026.
Louis Brooks. “Journal of Pharmaceutical Investigation Gains SciSearch Coverage and Q1 Impact Factor Standing.” Scienmag. September 22, 2026. https://scienmag.com/journal-of-pharmaceutical-investigation-gains-scisearch-coverage-and-q1-impact-factor-standing/
Copy citation
Download RIS
Tags: abstracting and indexingbibliographic database inclusionbibliometric analysis in pharmacologycitation tracking in pharmaceutical researchdrug development researchImpact Factorimpact factor of pharmaceutical journalsindexing in Science Citation Index Expandedjournal citation metricsJournal of Pharmaceutical Investigationpeer-reviewed pharmaceutical journalspharmaceutical sciencespharmaceutical technology advancementsPharmacology and PharmacyQ1 journalQ1 quartile ranking in pharmacyresearch evaluation in drug discoveryscholarly publishingscholarly visibility in natural sciencesScience Citation Index Expandedscientific publication recognitionSciSearchSpringerWeb of Science
